Depression treatment for Pompano Beach — measurement-based, 28 minutes away.

RECO Health's Delray Beach campus sits 18 miles north of Pompano Beach — 28 minutes up I-95 from Cresthaven, Lighthouse Point, and the Hillsboro Shores line. Depression care runs at the PHP and IOP levels with an in-house psychiatric team, and rTMS, IV ketamine, and esketamine (Spravato) are available onsite when two adequate antidepressant trials haven't produced remission. Every treatment plan is anchored to PHQ-9 trajectory and adjusted on measurement, not on clinical impression.

The drive from Pompano Beach north to RECO Health’s Delray Beach campus is 18 miles on I-95 — about 28 minutes outside rush hour. For clients based in Cresthaven, Lighthouse Point, Sea Ranch Lakes, and Hillsboro Shores, that trip puts genuine clinical separation between the daily routine that has kept a depressive episode entrenched and the treatment setting, while keeping care inside the same broader South Florida community. RECO Health provides depression treatment at the partial hospitalization (PHP) and intensive outpatient (IOP) levels of care, with in-house psychiatry, protocol-driven psychotherapy, and interventional options — rTMS, IV ketamine, and esketamine (Spravato) — when the standard treatment sequence hasn’t produced remission.

Diagnostic formulation and severity staging

The initial evaluation at RECO Health begins with a structured DSM-5-TR diagnostic interview. The clinical priority is separating major depressive disorder from persistent depressive disorder (dysthymia), bipolar depression, adjustment disorder with depressed mood, and depression secondary to a general medical condition or active substance use. That distinction matters — treating bipolar depression as unipolar with an SSRI carries a real risk of manic switch, and treating an untreated hypothyroid patient with sertraline addresses the symptom without touching the driver.

Severity is anchored to the PHQ-9. Scores at or above 20 with functional collapse, or any C-SSRS positive for active suicidal ideation with intent or plan, route the client to PHP. Moderate presentations — PHQ-9 in the 10-19 range without acute suicide risk — begin at IOP. Baseline labs (TSH, free T4, B12, folate, vitamin D, CMP, CBC) are reviewed to rule out medical contributors before pharmacotherapy is initiated.

Comorbidity screening is standard: GAD-7 for anxiety, ASRS for adult ADHD, PCL-5 for PTSD, AUDIT-C and DAST-10 for substance use. Fifty to sixty percent of clients presenting with major depression carry at least one comorbid condition; ignoring it produces partial responders and predictable relapse.

Pharmacology sequenced by evidence, not habit

First-line pharmacotherapy at RECO is an SSRI (sertraline, escitalopram) or SNRI (venlafaxine, duloxetine), titrated to a therapeutic dose and given a full 4-6 week response window before it is called a failure. Dose optimization comes before switching or augmentation — a sertraline trial capped at 50 mg is not an adequate trial, and calling it one leads to unnecessary polypharmacy.

Partial responders — a 25-50% reduction in PHQ-9 without remission — are augmented rather than switched. Evidence-based augmentation strategies include aripiprazole (2-5 mg), lithium titrated to a level of 0.6-0.8 mEq/L, quetiapine XR, or bupropion added to an SSRI. Non-responders are switched to a mechanistically distinct agent — an SSRI failure to venlafaxine or bupropion, not a serial rotation through the SSRI class.

When two adequate trials have failed, the STAR*D data are unambiguous: response rates to a third or fourth antidepressant fall below 15%. RECO does not cycle clients through a fifth agent at that point. Treatment-resistant depression triggers a structured evaluation for interventional treatment, and every medication decision — dose, duration, PHQ-9 trajectory, side effects — is logged so the treatment history is auditable rather than narrative.

Behavioral therapy modalities with evidence for depression

The therapy component is structured, not eclectic. Cognitive Behavioral Therapy (CBT) for depression targets the specific cognitive distortions — all-or-nothing thinking, catastrophizing, personalization — that maintain low mood, alongside the behavioral withdrawal that reinforces it. Behavioral Activation (BA) works from the outside in, scheduling rewarding and mastery activities before motivation returns; the evidence base for BA in moderate-to-severe depression is comparable to CBT.

Interpersonal Therapy (IPT) is used when a defined interpersonal trigger — grief, role transition, interpersonal dispute, or role deficit — anchors the depressive episode. For clients whose depression is trauma-linked, Cognitive Processing Therapy (CPT) or EMDR is layered into the plan; treating the depression without touching the underlying trauma yields incomplete responses. Acceptance and Commitment Therapy (ACT) and Motivational Interviewing (MI) contribute values-based behavioral commitment and change-language work, particularly for clients whose depression presents primarily as anhedonia and disengagement.

RECO’s therapists run these modalities to protocol — session-by-session structure, between-session homework, symptom tracking — rather than as a loose collection of techniques. Protocol adherence is what separates evidence-based therapy from generic supportive counseling.

Escalation pathway when medication and therapy aren’t enough

Roughly one third of clients with major depressive disorder will not achieve remission after two adequate antidepressant trials. RECO’s escalation pathway is defined in writing at intake so the client and family understand what happens next, rather than improvising after months of drift.

Repetitive transcranial magnetic stimulation (rTMS) is the FDA-cleared option for insurance-eligible treatment-resistant depression. The standard protocol is 10 Hz stimulation of the left dorsolateral prefrontal cortex, 3000 pulses per session at 120% of resting motor threshold, five sessions weekly for six weeks (36 total), with a taper. Response rates in TRD are approximately 50-55%, with remission near 30-35%.

For clients with acute suicidality, functional collapse, or an inability to wait six weeks for pharmacologic response, IV ketamine (0.5 mg/kg over 40 minutes, six-infusion induction over 2-3 weeks) produces response within hours to days. Esketamine (Spravato) offers a REMS-monitored intranasal alternative with more consistent commercial insurance coverage. Escalation moves on a schedule set at intake — not after another round of trying one more thing.

What to expect on your first visit

The initial visit runs two to three hours. It includes a psychiatric evaluation with a physician (60-90 minutes), a psychosocial assessment with the primary therapist, and baseline measures — PHQ-9, GAD-7, and C-SSRS at minimum; ASRS, PCL-5, AUDIT-C, and DAST-10 when the clinical picture warrants. Labs are drawn onsite if the standard panel hasn’t been completed in the prior six months.

Clients leave the first visit with a working diagnostic formulation, a level-of-care recommendation (PHP or IOP), a pharmacotherapy plan started or adjusted the same day when clinically indicated, and a scheduled therapy start. Family members or designated supports are invited into the closing portion of the visit with the client’s consent — early involvement predicts treatment retention better than most individual therapy variables.

Insurance and admissions from Pompano Beach

RECO Health is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS commercial plans. Admissions runs a real-time verification of benefits before intake, so PHP or IOP authorization, session limits, and out-of-pocket exposure are known before treatment begins, not after the first billing cycle.

For clients based in Pompano Beach, the drive is 18 miles up I-95 to the Atlantic Avenue or Linton Boulevard exits — 28 minutes off-peak, closer to 40 during weekday morning rush. IOP schedules are structured in dedicated morning and evening blocks so clients from Cresthaven, Lighthouse Point, and Sea Ranch Lakes can attend three-to-five days weekly without leaving employment; PHP schedules run a full clinical day with structured breaks and a supervised lunch.

Serving residents of: Cresthaven, Lighthouse Point, Sea Ranch Lakes, Hillsboro Shores.